Matches in SemOpenAlex for { <https://semopenalex.org/work/W2164678001> ?p ?o ?g. }
- W2164678001 endingPage "6721" @default.
- W2164678001 startingPage "6708" @default.
- W2164678001 abstract "// Sara Granja 1,2,* , Ibtissam Marchiq 3,* , Renaud Le Floch 3 , Conceição Souto Moura 5,6 , Fátima Baltazar 1,2,* and Jacques Pouysségur 3,4,* 1 Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal 2 ICVS/3B’s-PT Government Associate Laboratory, Braga/ Guimarães, Portugal 3 Institute for Research on Cancer and Aging of Nice (IRCAN), Centre A. Lacassagne, Nice, France 4 Centre Scientifique de Monaco (CSM), Monaco 5 Department of Pathology, Centro Hospitalar de São João, Porto, Portugal 6 Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) and Medical Faculty of University of Porto, Porto, Portugal * These authors contributed equally to this work Correspondence to: Fátima Baltazar, email: // Jacques Pouysségur, email: // Keywords : lung cancer, CD147, BASIGIN, monocarboxylate transporters, MCTs, lactate, glycolytic metabolism, metformin, ZFNs Received : June 25, 2014 Accepted : December 02, 2014 Published : December 03, 2014 Abstract Most cancers rely on aerobic glycolysis to generate energy and metabolic intermediates. To maintain a high glycolytic rate, cells must efficiently export lactic acid through the proton-coupled monocarboxylate transporters (MCT1/4). These transporters require a chaperone, CD147/BASIGIN (BSG) for trafficking to the plasma membrane and function. To validate the key role of these transporters in lung cancer, we first analysed the expression of MCT1/4 and BSG in 50 non-small lung cancer (NSCLC) cases. These proteins were specifically upregulated in tumour tissues. We then disrupted BSG in three NSCLC cell lines (A549, H1975 and H292) via ‘Zinc-Finger Nucleases’. The three homozygous BSG -/- cell lines displayed a low MCT activity (10- to 5-fold reduction, for MCT1 and MCT4, respectively) compared to wild-type cells. Consequently, the rate of glycolysis, compared to the wild-type counterpart, was reduced by 2.0- to 3.5-fold, whereas the rate of respiration was stimulated in BSG -/- cell lines. Both wild-type and BSG-null cells were extremely sensitive to the mitochondria inhibitor metformin/phenformin in normoxia. However, only BSG-null cells, independently of their LKB1 status , remained sensitive to biguanides in hypoxia in vitro and tumour growth in nude mice. Our results demonstrate that inhibiting glycolysis by targeting lactic acid export sensitizes NSCLC to phenformin." @default.
- W2164678001 created "2016-06-24" @default.
- W2164678001 creator A5000911874 @default.
- W2164678001 creator A5023130252 @default.
- W2164678001 creator A5042988285 @default.
- W2164678001 creator A5067891886 @default.
- W2164678001 creator A5085031489 @default.
- W2164678001 creator A5091254505 @default.
- W2164678001 date "2014-12-03" @default.
- W2164678001 modified "2023-10-16" @default.
- W2164678001 title "Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status" @default.
- W2164678001 cites W1748615418 @default.
- W2164678001 cites W1970002473 @default.
- W2164678001 cites W1975644528 @default.
- W2164678001 cites W1975701262 @default.
- W2164678001 cites W1976771782 @default.
- W2164678001 cites W1980094858 @default.
- W2164678001 cites W1981233558 @default.
- W2164678001 cites W1981989535 @default.
- W2164678001 cites W1995069275 @default.
- W2164678001 cites W1997224005 @default.
- W2164678001 cites W1997722072 @default.
- W2164678001 cites W2002752049 @default.
- W2164678001 cites W2019606372 @default.
- W2164678001 cites W2020988957 @default.
- W2164678001 cites W2027786827 @default.
- W2164678001 cites W2029142939 @default.
- W2164678001 cites W2034124119 @default.
- W2164678001 cites W2038623734 @default.
- W2164678001 cites W2043614750 @default.
- W2164678001 cites W2058106994 @default.
- W2164678001 cites W2062459035 @default.
- W2164678001 cites W2064218500 @default.
- W2164678001 cites W2064926668 @default.
- W2164678001 cites W2068045057 @default.
- W2164678001 cites W2083098214 @default.
- W2164678001 cites W2088441277 @default.
- W2164678001 cites W2092787533 @default.
- W2164678001 cites W2095699480 @default.
- W2164678001 cites W2116188697 @default.
- W2164678001 cites W2117692326 @default.
- W2164678001 cites W2119818544 @default.
- W2164678001 cites W2125836344 @default.
- W2164678001 cites W2135617839 @default.
- W2164678001 cites W2138784121 @default.
- W2164678001 cites W2140721007 @default.
- W2164678001 cites W2144204897 @default.
- W2164678001 cites W2150419930 @default.
- W2164678001 cites W2150458111 @default.
- W2164678001 cites W2160168375 @default.
- W2164678001 cites W2163754570 @default.
- W2164678001 cites W2165948908 @default.
- W2164678001 doi "https://doi.org/10.18632/oncotarget.2862" @default.
- W2164678001 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4466644" @default.
- W2164678001 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25894929" @default.
- W2164678001 hasPublicationYear "2014" @default.
- W2164678001 type Work @default.
- W2164678001 sameAs 2164678001 @default.
- W2164678001 citedByCount "50" @default.
- W2164678001 countsByYear W21646780012015 @default.
- W2164678001 countsByYear W21646780012016 @default.
- W2164678001 countsByYear W21646780012017 @default.
- W2164678001 countsByYear W21646780012018 @default.
- W2164678001 countsByYear W21646780012019 @default.
- W2164678001 countsByYear W21646780012020 @default.
- W2164678001 countsByYear W21646780012021 @default.
- W2164678001 countsByYear W21646780012022 @default.
- W2164678001 countsByYear W21646780012023 @default.
- W2164678001 crossrefType "journal-article" @default.
- W2164678001 hasAuthorship W2164678001A5000911874 @default.
- W2164678001 hasAuthorship W2164678001A5023130252 @default.
- W2164678001 hasAuthorship W2164678001A5042988285 @default.
- W2164678001 hasAuthorship W2164678001A5067891886 @default.
- W2164678001 hasAuthorship W2164678001A5085031489 @default.
- W2164678001 hasAuthorship W2164678001A5091254505 @default.
- W2164678001 hasBestOaLocation W21646780011 @default.
- W2164678001 hasConcept C104317684 @default.
- W2164678001 hasConcept C109523444 @default.
- W2164678001 hasConcept C126322002 @default.
- W2164678001 hasConcept C127561419 @default.
- W2164678001 hasConcept C143998085 @default.
- W2164678001 hasConcept C149011108 @default.
- W2164678001 hasConcept C161573976 @default.
- W2164678001 hasConcept C185592680 @default.
- W2164678001 hasConcept C20251656 @default.
- W2164678001 hasConcept C2775920511 @default.
- W2164678001 hasConcept C2776126859 @default.
- W2164678001 hasConcept C2776256026 @default.
- W2164678001 hasConcept C2779306644 @default.
- W2164678001 hasConcept C2781217356 @default.
- W2164678001 hasConcept C502942594 @default.
- W2164678001 hasConcept C523546767 @default.
- W2164678001 hasConcept C54355233 @default.
- W2164678001 hasConcept C55493867 @default.
- W2164678001 hasConcept C55885012 @default.
- W2164678001 hasConcept C62231903 @default.
- W2164678001 hasConcept C71924100 @default.
- W2164678001 hasConcept C86803240 @default.